To investigate if act-MMP-3 levels responded to anti-TNF-α treatment, we measured serum levels of act-MMP-3 in AS and RA patients at baseline and after anti-TNF-α treatment. The gene discussed is MMP3; the disease is rheumatoid arthritis.